Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: The Pan-Canadian Oncology Drug Review

Research output: Contribution to journal › Article

Cite this

@article{4ede6771f7de4389b14399e6c356b8d9,

title = "Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: The Pan-Canadian Oncology Drug Review",

author = "Hoch, {Jeffrey S} and M. Sabharwal",

year = "2013",

doi = "10.3747/co.20.1315",

language = "English (US)",

volume = "20",

pages = "121--124",

journal = "Current Oncology",

issn = "1198-0052",

publisher = "Multimed Inc.",

number = "2",

}

TY - JOUR

T1 - Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives

T2 - The Pan-Canadian Oncology Drug Review

AU - Hoch, Jeffrey S

AU - Sabharwal, M.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84875874701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875874701&partnerID=8YFLogxK

U2 - 10.3747/co.20.1315

DO - 10.3747/co.20.1315

M3 - Article

C2 - 23559876

AN - SCOPUS:84875874701

VL - 20

SP - 121

EP - 124

JO - Current Oncology

JF - Current Oncology

SN - 1198-0052

IS - 2

ER -